Data as of November 21, 2026
Neurontin 300 mg Capsule
GABAPENTIN
Brand: Neurontin
Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.
Price per fill
NADAC (acquisition)
$842.51/ fill$7.36 / EA
VA Big4
$626.43/ fill$5.48 / EA
FUL
$7.86/ fill$0.07 / EA
AMP
$4.49/ fill$0.04 / EA
Medicaid FFS
$666.59/ fill
Medicaid MCO
$824.51/ fill
Sources: cms/nadac:price-ladder · va/fss-drug-prices:normalized · cms/ful:generic-ceiling · cms/sdud
What's in the reimbursement
Ingredient cost (114.4 units/fill)$842.51
Dispensing fee & other (state-fixed, not margin)-$175.92
Total reimbursed per fill$666.59
The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.
Medicaid volume backing this card: 3 fee-for-service states, 1 managed-care states.
Full methodology and source columns: /tools/drug-prices/methodology